サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1280000

医薬品製造装置の世界市場：装置の種類別 (包装機、混合・ブレンド装置、充填機、粉砕機、噴霧乾燥装置、検査装置、押出装置、錠剤圧縮機)・最終製品の種類別 (固体、液体)・地域別の将来予測 (2028年まで)

Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Mixing & Blending, Filling, Milling, Spray Drying, Inspection, Extrusion, Tablet Compression Presses), End-Product Type (Solid, Liquid) and Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 217 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
医薬品製造装置の世界市場：装置の種類別 (包装機、混合・ブレンド装置、充填機、粉砕機、噴霧乾燥装置、検査装置、押出装置、錠剤圧縮機)・最終製品の種類別 (固体、液体)・地域別の将来予測 (2028年まで)
出版日: 2023年05月18日
発行: MarketsandMarkets
ページ情報: 英文 217 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品製造装置の市場規模は、2023年の145億米ドルから2028年には197億米ドルに達すると予測され、2023年から2028年までのCAGRは6.3%となります。

医薬品製造装置市場の成長を促す主な要因としては、医薬品の革新性や安全性をサポートするために世界中で確立された規制枠組みの増加、世界のジェネリック医薬品の需要拡大、医療投資の増加、医薬品製造における柔軟性への要求の高まりなどが挙げられます。また、中東・アフリカを中心とした医薬品製造の新興市場も、技術的に高度な医薬品製造装置への需要を促進する重要な要因となっています。

"予測期間中、最も高いCAGRを記録すると予想されるのは包装機で、噴霧乾燥機が続く"

医薬品包装機は、医薬品の品質と安全性を確保し、規制要件を満たすために、医薬品製造プロセスにおいて重要な役割を果たします。シリアル化機能を備えた包装機は、個々の医薬品のユニークな識別と追跡を可能にし、サプライチェーンの透明性と製品の認証を容易にするため、その需要を促進しています。製薬業界では、持続可能な包装を重視する傾向が強まっています。リサイクル可能な素材や生分解性素材など、環境に配慮した包装材をサポートする包装機が求められています。医薬品の噴霧乾燥装置を使用すると、医薬品有効成分 (API) が製剤中に均一に分散され、最終製品が品質、純度、効力の要求仕様に適合するようにすることができます。製剤を効率的かつ正確に噴霧乾燥することは、患者が安全に使用できる高品質の医薬品を製造するために不可欠であり、それによって需要が促進されます。

"予測期間中、液体最終製品タイプが最も高いCAGRで成長し、固体最終製品タイプがそれに続く"

液体製品タイプは、溶液・シロップ・懸濁液・乳剤など、さまざまな種類の液体剤形をカバーしています。シロップの需要が高まっています。濃縮された糖液に薬剤を正確に投与することができるため、不快な味を隠すことができ、特に老人や子供に好まれます。技術進歩、広範な研究開発活動、臨床試験の革新により、メーカーは液体製剤の保存性を大幅に向上させ、溶解度の低い多くの固体製剤に代わる実現可能な製剤とすることができました。液剤は固形剤に比べてバイオアベイラビリティが高く、有効成分がより多く血流に吸収されることを意味します。これは、より効果的な治療と副作用のリスクの低減につながる可能性があり、これも需要を促進する要因となっています。

"予測期間中、アジア太平洋が最も高いCAGRを記録すると予想され、欧州がそれに続く"

アジア太平洋の業界各社は、医薬品不足に対処するため、政府と協力しながら取り組んでいます。さらに、ブランド医薬品の高騰や主要医薬品の特許切れも、ジェネリック医薬品の採用需要を後押ししています。この地域の政府や業界関係者は、増大する医薬品需要に対応し、医薬品不足を解消し、生産能力を拡大するために、最新の医薬品製造装置を導入して医薬品製造施設の改善を図ることを目的としています。インドは米国以外で最も多くの米国FDA準拠の製薬工場を有しています。3,000社以上の製薬会社が存在し、10,500以上の製造施設と高度なスキルを持つ人材プールの強力なネットワークがあります。さらに、インド政府は、世界サプライチェーン全体で高価値製品を含む国内製造能力を高めるために、生産連動インセンティブ (PLI) スキームなどのスキームを導入しています。

ドイツは2021年度、医薬品の輸入・輸出の上位に位置する国です。有利な政策枠組みの存在、確立された医療制度、医薬品研究開発費の増加、ブランド医薬品とジェネリック医薬品の需要増が、同国の医薬品市場の潜在力を高める主な要因となっています。ドイツには、Bayer、Merck KGaA、Boehringer Ingelheimなど、複数の大手製薬会社が存在します。複数の製薬会社は、同国に複数の主要な医薬品製造施設が存在することを示し、同国全体で医薬品製造装置の採用を後押ししています。フランス政府は、規制プロセスを合理化し、研究開発を促進するためにいくつかの施策を実施しました。例えば、2023年には、政府は、フランスの製薬業界、医療専門家、患者の代表者を含む新たな専門委員会を設立し、サプライチェーンの問題を予防・管理するための長期的なアプローチの基礎を築く予定です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • バリューチェーン分析
  • エコシステムマッピング
  • 価格分析
  • 顧客のビジネスに影響を与える動向/混乱
  • 技術分析
  • ポーターのファイブフォース分析
  • 主要な利害関係者と購入基準
  • ケーススタディ
  • 貿易分析
  • 特許分析
  • 主要な会議とイベント (2022年～2023年)
  • 規制と基準

第6章 医薬品製造装置市場：装置の種類別

  • イントロダクション
  • 包装機
  • 充填機
  • 噴霧乾燥装置
  • 混合・ブレンド装置
  • 粉砕機
  • 押出装置
  • 錠剤圧縮機
  • 検査装置

第7章 医薬品製造装置市場：最終製品の種類別

  • イントロダクション
  • 固体
  • 液体

第8章 医薬品製造装置市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • その他アジア太平洋
  • その他の地域
    • 中東・アフリカ
    • 南米

第9章 競合情勢

  • 概要
  • 上位5社の収益分析
  • 市場シェア分析 (2022年)
  • 企業評価クアドラント
  • 中小企業評価クアドラント (2022年)
  • 医薬品包装機市場：企業のフットプリント
  • 競合ベンチマーキング
  • 競合状況・動向

第10章 企業プロファイル

  • 主要企業
    • GEA GROUP AKTIENGESELLSCHAFT
    • I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A
    • SYNTEGON TECHNOLOGY GMBH
    • ACG
    • THERMO FISHER SCIENTIFIC INC.
    • ROMACO GROUP
    • KORBER AG
    • MARCHESINI GROUP
    • MG2 S.R.L
    • GLATT GMBH
  • その他の企業
    • BAKER PERKINS
    • BAUSCH+STROBEL
    • COPERION
    • ELIZABETH COMPANIES
    • FETTE COMPACTING
    • FREUND-VECTOR
    • KORSCH
    • L.B. BOHLE
    • LFA MACHINES
    • CVC TECHNOLOGIES, INC.
    • OHARA TECHNOLOGIES
    • PRISM PHARMA MACHINERY
    • SAINTYCO
    • SILVERSON
    • YENCHEN MACHINERY

第11章 隣接・関連市場

第12章 付録

目次
Product Code: SE 8645

The pharmaceutical manufacturing equipment market is projected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% from 2023 to 2028. The major factors driving the market growth of the pharmaceutical manufacturing equipment market include increasing number of regulatory frameworks established worldwide to support innovation and safety in drugs, growing demand for generics globally, rising healthcare investment, and growing requirement for flexibility in pharmaceutical manufacturing. Emerging markets for pharmaceutical manufacturing, especially in the Middle East and Africa, is also a key factor driving the demand for technologically advanced pharmaceutical manufacturing equipment.

Packaging machines are expected to register the highest CAGR during the forecast period followed by spray drying equipment

Pharmaceutical packaging machines are critical in the drug manufacturing process as they ensure the quality and safety of medications while meeting regulatory requirements. ackaging machines equipped with serialization capabilities enable unique identification and tracking of individual pharmaceutical products, facilitating supply chain transparency and product authentication, thereby driving their demand. There is a growing emphasis on sustainable packaging practices in the pharmaceutical industry. Packaging machines that support eco-friendly packaging materials, such as recyclable or biodegradable materials, are in demand. Using pharmaceutical spray drying equipment helps ensure that the active pharmaceutical ingredient (API) is evenly distributed throughout the drug formulation and that the final product meets the required specifications for quality, purity, and potency. The efficient and precise spray drying of drug formulations is essential to produce high-quality drug products that are safe and effective for patient use, thereby driving their demand.

Liquid end-product type is expected to register the highest CAGR during the forecast period followed by solid end-product type

Liquid end-product type covers different types of liquid dosage forms including solutions, syrups, suspensions, and emulsions, among others. There is a growing demand for syrups. They offer accurate dosage of drug in a concentrated sugar solution, thus masking the unpleasant taste and therefore being preferred, especially by the geriatric population and children. Technological advancements, extensive research and development activities, and innovation in clinical trials have allowed manufacturers to substantially enhance shelf-life of liquid dosage forms, thereby making them a feasible alternative to many solid dosage forms which have less solubility. Liquid medications have higher bioavailability compared to solid dosage forms, meaning that more of the active ingredient is absorbed into the bloodstream. This can lead to a more effective treatment and a reduced risk of side effects, which is another factor driving their demand.

Asia Pacific is expected to register the highest CAGR during forecast period followed by Europe

Industry players in Asia Pacific are working collaboratively with the government to tackle the shortages of drugs. In addition, high-rate of branded drugs and the expiry of key drug patents are also driving the demand for the adoption of generics. The governments and industry players across the region aim to improve pharmaceutical manufacturing facilities by adopting the latest pharmaceutical manufacturing equipment to serve the growing demand for drugs, eliminate drug shortages, and expand production capacities. India has the highest number of US-FDA-compliant pharma plants outside the US. It is home to over 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities and a highly skilled resource pool. Furthermore, the government of India has implemented schemes, including the Production Linked Incentive (PLI) scheme to boost domestic manufacturing capacity, including high-value products across the global supply chain.

Germany was one of the top importers and exporters of pharmaceutical products in FY 2021. The presence of a favorable policy framework, a well-established healthcare system, increasing pharmaceutical R&D expenditure, and rising demand for branded and generic drugs are the major factors driving the potential of the pharmaceutical market in the country. Germany is home to several major pharmaceutical companies, including Bayer, Merck KGaA, Boehringer Ingelheim, etc. Several pharmaceutical companies indicate the presence of several major pharmaceutical manufacturing facilities in the country, boosting the adoption of pharmaceutical manufacturing equipment across the country. The French government implemented several measures to streamline the regulatory process and promote research and development. For instance, in 2023, the government will form a new dedicated committee, which will include representatives of the French pharma industry, health professionals, and patients to lay the foundations for a longer-term approach to preventing and managing supply chain issues.

The break-up of profile of primary participants in the pharmaceutical manufacturing equipment market-

  • By Company Type: Tier 1 - 40%, Tier 2 - 35%, Tier 3 - 25%
  • By Designation Type: C Level - 48%, Director Level - 33% , Others - 19%
  • By Region Type: North America - 35%, Europe - 18%, Asia Pacific - 40%, Rest of the World - 7%

The major players of pharmaceutical manufacturing equipment market are GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US) among others.

Research Coverage

The report segments the pharmaceutical manufacturing equipment market and forecasts its size based on equipment type, end-product type, and region. The report also provides a comprehensive review of drivers, restraints, opportunities, and challenges influencing the market growth. The report also covers qualitative aspects in addition to the quantitative aspects of the market.

Reasons to buy the report:

The report will help the market leaders/new entrants in this market with information on the closest approximate revenues for the overall pharmaceutical manufacturing equipment market and related segments. This report will help stakeholders understand the competitive landscape and gain more insights to strengthen their position in the market and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (globally increasing demand for generics, rising need for flexible pharmaceutical manufacturing, and growing implementation of regulatory frameworks and guidelines), restraints (increasing global demand for refurbished pharmaceutical manufacturing equipment), opportunities (adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages, emerging markets and increasing focus on sustainability, and integration of artificial intelligence (AI) with inspection equipment to provide better quality assurance), and challenges (rising costs and expenditures related to usage of pharmaceutical manufacturing equipment) influencing the growth of the pharmaceutical manufacturing equipment market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pharmaceutical manufacturing equipment market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the pharmaceutical manufacturing equipment market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical manufacturing equipment market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
    • TABLE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: INCLUSIONS AND EXCLUSIONS
  • 1.4 STUDY SCOPE
    • 1.4.1 MARKETS COVERED
    • FIGURE 1 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: SEGMENTATION
    • 1.4.2 GEOGRAPHICAL SCOPE
    • FIGURE 2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: GEOGRAPHIC SEGMENTATION
    • 1.4.3 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY AND PRIMARY RESEARCH
    • 2.1.2 SECONDARY DATA
      • 2.1.2.1 Major secondary sources
      • 2.1.2.2 Key data from secondary sources
    • 2.1.3 PRIMARY DATA
      • 2.1.3.1 Primary interviews with experts
      • 2.1.3.2 Key data from primary sources
      • 2.1.3.3 Key industry insights
      • 2.1.3.4 Breakdown of primaries
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE): REVENUE GENERATED FROM PHARMACEUTICAL PACKAGING MACHINES IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach to arrive at market size through bottom-up analysis (demand side)
    • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to arrive at market size through top-down analysis (supply side)
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • FIGURE 8 ASSUMPTIONS FOR RESEARCH STUDY
  • 2.5 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT
  • 2.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT
    • TABLE 2 LIMITATIONS AND ASSOCIATED RISKS

3 EXECUTIVE SUMMARY

    • FIGURE 9 PACKAGING MACHINES TO HOLD DOMINANT SHARE OF MARKET
    • FIGURE 10 LIQUID END PRODUCT TYPE TO CLAIM LARGEST SHARE IN MARKET
    • FIGURE 11 ASIA PACIFIC HELD LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN 2022

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE GROWTH OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 12 RISING DEMAND FOR GENERICS AND GROWING NECESSITY FOR FLEXIBLE PHARMACEUTICAL MANUFACTURING TO PROVIDE OPPORTUNITIES FOR PLAYERS IN MARKET
  • 4.2 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
    • FIGURE 13 PACKAGING MACHINES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE
    • FIGURE 14 LIQUID SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY
    • FIGURE 15 US TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising demand for generics
      • 5.2.1.2 Need for flexible pharmaceutical manufacturing
      • 5.2.1.3 Growing implementation and adoption of regulatory guidelines
    • FIGURE 17 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Demand for refurbished equipment
    • FIGURE 18 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages
      • 5.2.3.2 Integration of artificial intelligence with inspection equipment to provide better quality assurance
      • 5.2.3.3 Emerging markets and increased focus on sustainability
    • FIGURE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment
    • FIGURE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: IMPACT ANALYSIS OF CHALLENGES
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 21 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM MAPPING
    • FIGURE 22 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
    • TABLE 3 COMPANIES AND THEIR ROLE IN PHARMACEUTICAL MANUFACTURING EQUIPMENT ECOSYSTEM
  • 5.5 PRICING ANALYSIS
    • 5.5.1 COMPANY-WISE AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE
    • TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT, BY EQUIPMENT TYPE
    • FIGURE 23 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT BY KEY PLAYERS, BY EQUIPMENT TYPE (USD)
    • TABLE 5 AVERAGE SELLING PRICE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT OFFERED BY THREE GLOBAL PLAYERS, BY EQUIPMENT TYPE
    • TABLE 6 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, BY REGION
    • FIGURE 24 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING MACHINE, 2019-2028
  • 5.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 INDUSTRY 4.0
    • 5.7.2 COMPUTER VISION
    • 5.7.3 RADIO FREQUENCY IDENTIFICATION
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 26 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 BARGAINING POWER OF SUPPLIERS
    • 5.8.2 BARGAINING POWER OF BUYERS
    • 5.8.3 THREAT OF NEW ENTRANTS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS IN PHARMACEUTICAL INDUSTRY ON BUYING PROCESS
    • TABLE 7 INFLUENCE OF STAKEHOLDERS IN TOP THREE END-USER INDUSTRIES ON BUYING PROCESS
    • 5.9.2 BUYING CRITERIA
    • FIGURE 28 KEY BUYING CRITERIA FOR PHARMACEUTICAL INDUSTRY
    • TABLE 8 KEY BUYING CRITERIA OF TOP THREE INDUSTRIES
  • 5.10 CASE STUDIES
    • TABLE 9 ALCAMI CORPORATION CHOOSES SYNTEGON TO INCREASE ITS VIAL FILLING FLEXIBILITY
    • TABLE 10 LEADING MANUFACTURER OF GENERIC DRUG PRODUCTS IN RUSSIA CHOOSES GEA GROUP TO EXPAND THEIR REACH AND INTEGRATE ADVANCED MANUFACTURING EQUIPMENT
    • TABLE 11 CDM LAVOISIER ADOPTS SYNTEGON AIM 3000 FOR INSPECTION OF 30 DIFFERENT PRODUCTS ON FOUR PACKAGING FORMATS
  • 5.11 TRADE ANALYSIS
    • FIGURE 29 IMPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017-2021 (USD MILLION)
    • FIGURE 30 EXPORT DATA FOR MACHINERY FOR FILLING, CLOSING, SEALING, OR LABELLING BOTTLES, CANS, BOXES, BAGS, OR OTHER CONTAINERS; MACHINERY FOR CAPSULING BOTTLES, JARS, TUBES, AND SIMILAR CONTAINERS; MACHINERY FOR AERATING BEVERAGES, 2017-2021 (USD MILLION)
  • 5.12 PATENT ANALYSIS
    • 5.12.1 LIST OF MAJOR PATENTS
    • TABLE 12 KEY PATENTS IN AREA OF PHARMACEUTICAL MANUFACTURING EQUIPMENT
  • 5.13 KEY CONFERENCES AND EVENTS, 2022-2023
    • TABLE 13 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: REGION-WISE CONFERENCES AND EVENTS
  • 5.14 REGULATIONS AND STANDARDS
    • 5.14.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.14.2 STANDARDS
    • TABLE 18 STANDARDS FOLLOWED BY MANUFACTURERS OF PHARMACEUTICAL MANUFACTURING EQUIPMENT

6 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE

  • 6.1 INTRODUCTION
    • FIGURE 31 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE
    • FIGURE 32 PACKAGING MACHINES TO LEAD MARKET THROUGHOUT FORECAST PERIOD
    • TABLE 19 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 20 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
  • 6.2 PACKAGING MACHINES
    • 6.2.1 RISING NECESSITY FOR ENSURING PROTECTION AGAINST DAMAGE AND CONTAMINATION
    • TABLE 21 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 22 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 23 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 24 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 25 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 26 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 27 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 28 PACKAGING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.3 FILLING MACHINES
    • 6.3.1 GROWING DEMAND FOR ENSURING PRECISION FILLING OF DRUG FORMULATIONS
    • TABLE 29 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 30 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 31 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 32 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 33 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 34 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 35 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 36 FILLING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.4 SPRAY DRYING EQUIPMENT
    • 6.4.1 GROWING NECESSITY FOR HIGH-QUALITY DRUGS
    • TABLE 37 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 38 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 39 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 40 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 41 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 42 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 43 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 44 SPRAY DRYING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.5 MIXING AND BLENDING MACHINES
    • 6.5.1 DEMAND TO MAINTAIN UNIFORMITY OF DRUG FORMULATIONS FOR HOMOGENEITY TO DRIVE MARKET
    • TABLE 45 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 46 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 47 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 48 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 49 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 50 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 51 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 52 MIXING AND BLENDING MACHINES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.6 MILLING EQUIPMENT
    • 6.6.1 RISING NECESSITY TO IMPROVE SOLUBILITY OF DRUGS
    • TABLE 53 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 54 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 55 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 56 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 57 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 58 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 59 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 60 MILLING EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.7 EXTRUSION EQUIPMENT
    • 6.7.1 NECESSITY FOR DEVELOPING DRUGS IN EFFECTIVE SHAPES AND MAINTAINING PROPER DRUG FORMULATION
    • TABLE 61 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 62 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 63 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 64 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 65 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 66 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 67 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 68 EXTRUSION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.8 TABLET COMPRESSION PRESSES
    • 6.8.1 RISING DEMAND TO PRODUCE LARGE BATCHES OF TABLETS QUICKLY
    • TABLE 69 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 70 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 71 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 72 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 73 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 74 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 75 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 76 TABLET COMPRESSION PRESSES: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)
  • 6.9 INSPECTION EQUIPMENT
    • 6.9.1 RISING DEMAND TO ADHERE TO QUALITY STANDARDS
    • TABLE 77 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 78 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 79 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 80 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN NORTH AMERICA, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 81 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 82 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN EUROPE, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 83 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 84 INSPECTION EQUIPMENT: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ASIA PACIFIC, BY COUNTRY, 2023-2028 (USD MILLION)

7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE

  • 7.1 INTRODUCTION
    • FIGURE 33 LIQUID END-PRODUCT TYPE TO HOLD LARGER MARKET SHARE THROUGHOUT FORECAST PERIOD
    • TABLE 85 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2019-2022 (USD MILLION)
    • TABLE 86 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY END-PRODUCT TYPE, 2023-2028 (USD MILLION)
  • 7.2 SOLID
    • 7.2.1 RISING DEMAND FOR TABLETS
  • 7.3 LIQUID
    • 7.3.1 EASE OF ADMINISTRATION AND HIGH SOLUBILITY

8 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION

  • 8.1 INTRODUCTION
    • FIGURE 34 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • FIGURE 35 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 87 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 88 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 36 NORTH AMERICA: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 37 US TO REGISTER HIGHEST CAGR IN NORTH AMERICAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 89 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 90 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 91 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 92 US: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 93 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 94 CANADA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 95 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 96 MEXICO: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 98 NORTH AMERICA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.2.1 US
      • 8.2.1.1 Stringent regulatory framework and growing demand for innovative drugs
    • 8.2.2 CANADA
      • 8.2.2.1 Establishment of new drug development facilities and government measures
    • 8.2.3 MEXICO
      • 8.2.3.1 Development of pharmaceutical manufacturing units by global players
  • 8.3 EUROPE
    • FIGURE 38 EUROPE: SNAPSHOT OF PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
    • FIGURE 39 GERMANY TO REGISTER HIGHEST CAGR IN EUROPEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 99 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 100 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 101 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 102 UK: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 103 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 104 GERMANY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 105 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 106 FRANCE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 107 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 108 ITALY: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 109 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 110 EUROPE: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.3.1 UK
      • 8.3.1.1 Strong pharmaceutical manufacturing sector
    • 8.3.2 GERMANY
      • 8.3.2.1 Presence of major pharmaceutical players
    • 8.3.3 FRANCE
      • 8.3.3.1 Growing demand for generics
    • 8.3.4 ITALY
      • 8.3.4.1 Growing government support
    • 8.3.5 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SNAPSHOT
    • FIGURE 41 INDIA TO REGISTER HIGHEST CAGR IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET DURING FORECAST PERIOD
    • TABLE 111 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2019-2022 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 113 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 114 CHINA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 115 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 116 JAPAN: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 117 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 118 INDIA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 119 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 120 SOUTH KOREA: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 122 ASIA PACIFIC: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.4.1 CHINA
      • 8.4.1.1 Growing contract pharmaceutical manufacturing
    • 8.4.2 JAPAN
      • 8.4.2.1 Collaboration of associations and industry players to eliminate drug shortages
    • 8.4.3 INDIA
      • 8.4.3.1 Establishment of new pharmaceutical manufacturing units
    • 8.4.4 SOUTH KOREA
      • 8.4.4.1 Increasing government initiatives to support market growth
    • 8.4.5 REST OF ASIA PACIFIC
  • 8.5 REST OF THE WORLD
    • FIGURE 42 SOUTH AMERICA TO DOMINATE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW DURING FORECAST PERIOD
    • TABLE 123 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 124 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET IN ROW, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 125 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2019-2022 (USD MILLION)
    • TABLE 126 ROW: PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, BY EQUIPMENT TYPE, 2023-2028 (USD MILLION)
    • 8.5.1 MIDDLE EAST & AFRICA
      • 8.5.1.1 Growing regulatory environment
    • 8.5.2 SOUTH AMERICA
      • 8.5.2.1 Growing pharmaceutical manufacturing infrastructure

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
    • TABLE 127 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET
  • 9.2 REVENUE ANALYSIS OF TOP FIVE PLAYERS
    • FIGURE 43 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS (2022)
  • 9.3 MARKET SHARE ANALYSIS, 2022
    • TABLE 128 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE OF KEY COMPANIES
    • FIGURE 44 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: MARKET SHARE ANALYSIS
  • 9.4 COMPANY EVALUATION QUADRANT
    • 9.4.1 STARS
    • 9.4.2 EMERGING LEADERS
    • 9.4.3 PERVASIVE PLAYERS
    • 9.4.4 PARTICIPANTS
    • FIGURE 45 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY EVALUATION QUADRANT, 2022
  • 9.5 SMALL- AND MEDIUM-SIZED ENTERPRISES EVALUATION QUADRANT, 2022
    • 9.5.1 PROGRESSIVE COMPANIES
    • 9.5.2 RESPONSIVE COMPANIES
    • 9.5.3 DYNAMIC COMPANIES
    • 9.5.4 STARTING BLOCKS
    • FIGURE 46 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET (GLOBAL): SME EVALUATION QUADRANT, 2022
  • 9.6 PHARMACEUTICAL PACKAGING EQUIPMENT MARKET: COMPANY FOOTPRINT
    • TABLE 129 COMPANY FOOTPRINT
    • TABLE 130 PRIMARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT
    • TABLE 131 SECONDARY PACKAGING EQUIPMENT: COMPANY FOOTPRINT
    • TABLE 132 TYPE: COMPANY FOOTPRINT
    • TABLE 133 REGION: COMPANY FOOTPRINT
  • 9.7 COMPETITIVE BENCHMARKING
    • TABLE 134 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 135 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 9.8 COMPETITIVE SITUATIONS AND TRENDS
    • 9.8.1 PRODUCT LAUNCHES
    • TABLE 136 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: PRODUCT LAUNCHES, APRIL 2020-JANUARY 2023
    • 9.8.2 DEALS
    • TABLE 137 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: DEALS, JANUARY 2021-MARCH 2023

10 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 10.1 KEY PLAYERS
    • 10.1.1 GEA GROUP AKTIENGESELLSCHAFT
    • TABLE 138 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
    • FIGURE 47 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT
    • TABLE 139 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 140 GEA GROUP AKTIENGESELLSCHAFT: PRODUCT LAUNCHES & DEVELOPMENTS
    • TABLE 141 GEA GROUP AKTIENGESELLSCHAFT: DEALS
    • 10.1.2 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A
    • TABLE 142 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A : COMPANY OVERVIEW
    • TABLE 143 I.M.A INDUSTRIA MACCHINE AUTOMATICHE S.P.A: PRODUCT/SOLUTIONS/SERVICES OFFERED
    • 10.1.3 SYNTEGON TECHNOLOGY GMBH
    • TABLE 144 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW
    • TABLE 145 SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 146 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES
    • TABLE 147 SYNTEGON TECHNOLOGY GMBH: DEALS
    • 10.1.4 ACG
    • TABLE 148 ACG: COMPANY OVERVIEW
    • TABLE 149 ACG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 10.1.5 THERMO FISHER SCIENTIFIC INC.
    • TABLE 150 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    • TABLE 151 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 152 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 10.1.6 ROMACO GROUP
    • TABLE 153 ROMACO GROUP: COMPANY OVERVIEW
    • TABLE 154 ROMACO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 155 ROMACO GROUP: PRODUCT LAUNCHES
    • TABLE 156 ROMACO GROUP: DEALS
    • 10.1.7 KORBER AG
    • TABLE 157 KORBER AG: COMPANY OVERVIEW
    • FIGURE 49 KORBER AG: COMPANY SNAPSHOT
    • TABLE 158 KORBER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 159 KORBER AG: DEALS
    • 10.1.8 MARCHESINI GROUP
    • TABLE 160 MARCHESINI GROUP: COMPANY OVERVIEW
    • TABLE 161 MARCHESINI GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 162 MARCHESINI GROUP: PRODUCT LAUNCHES
    • TABLE 163 MARCHESINI GROUP: DEALS
    • 10.1.9 MG2 S.R.L
    • TABLE 164 MG2 S.R.L.: COMPANY OVERVIEW
    • TABLE 165 MG2 S.R.L.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 166 MG2 S.R.L.: PRODUCT LAUNCHES
    • 10.1.10 GLATT GMBH
    • TABLE 167 GLATT GMBH: COMPANY OVERVIEW
    • TABLE 168 GLATT GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 10.2 OTHER PLAYERS
    • 10.2.1 BAKER PERKINS
    • TABLE 169 BAKER PERKINS: COMPANY OVERVIEW
    • 10.2.2 BAUSCH+STROBEL
    • TABLE 170 BAUSCH+ STROBEL: COMPANY OVERVIEW
    • 10.2.3 COPERION
    • TABLE 171 COPERION: COMPANY OVERVIEW
    • 10.2.4 ELIZABETH COMPANIES
    • TABLE 172 ELIZABETH COMPANIES: COMPANY OVERVIEW
    • 10.2.5 FETTE COMPACTING
    • TABLE 173 FETTE COMPACTING: COMPANY OVERVIEW
    • 10.2.6 FREUND-VECTOR
    • TABLE 174 FREUND-VECTOR: COMPANY OVERVIEW
    • 10.2.7 KORSCH
    • TABLE 175 KORSCH: COMPANY OVERVIEW
    • 10.2.8 L.B. BOHLE
    • TABLE 176 L.B. BOHLE: COMPANY OVERVIEW
    • 10.2.9 LFA MACHINES
    • TABLE 177 LFA MACHINES: COMPANY OVERVIEW
    • 10.2.10 CVC TECHNOLOGIES, INC.
    • TABLE 178 CVC TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • 10.2.11 OHARA TECHNOLOGIES
    • TABLE 179 OHARA TECHNOLOGIES: COMPANY OVERVIEW
    • 10.2.12 PRISM PHARMA MACHINERY
    • TABLE 180 PRISM PHARMA MACHINERY: COMPANY OVERVIEW
    • 10.2.13 SAINTYCO
    • TABLE 181 SAINTYCO: COMPANY OVERVIEW
    • 10.2.14 SILVERSON
    • TABLE 182 SILVERSON: COMPANY OVERVIEW
    • 10.2.15 YENCHEN MACHINERY
    • TABLE 183 YENCHEN MACHINERY: COMPANY OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

11 ADJACENT AND RELATED MARKETS

  • 11.1 INTRODUCTION
  • 11.2 LIMITATIONS
  • 11.3 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT
    • 11.3.1 INTRODUCTION
    • TABLE 184 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2019-2022 (USD MILLION)
    • TABLE 185 SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY SUPPLY CHAIN PARTICIPANT, 2023-2028 (USD MILLION)
  • 11.4 IDM FIRMS
    • 11.4.1 FOCUS ON SEMICONDUCTOR DESIGN AND PRODUCTION AND HAVE INTERNAL CAPABILITY TO PERFORM BOTH
    • TABLE 186 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 187 IDM FIRMS: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.5 OSAT COMPANIES
    • 11.5.1 LESS INVESTMENTS AND ATTRACTIVE REVENUE FOSTER GROWTH OF OSAT COMPANIES
    • TABLE 188 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 189 OSAT COMPANIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.6 FOUNDRIES
    • 11.6.1 INCREASED SEMICONDUCTOR OUTSOURCING BY FABLESS COMPANIES
    • TABLE 190 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2019-2022 (USD MILLION)
    • TABLE 191 FOUNDRIES: SEMICONDUCTOR MANUFACTURING EQUIPMENT MARKET, BY REGION, 2023-2028 (USD MILLION)

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 CUSTOMIZATION OPTIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS